Headlands Technologies’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Buy
60,313
+14,434
+31% +$31.3K 0.01% 660
2025
Q4
$108K Buy
45,879
+12,768
+39% +$34.9K 0.01% 626
2025
Q3
$101K Sell
33,111
-71,468
-68% -$204K 0.01% 573
2025
Q2
$292K Buy
104,579
+103,854
+14,325% +$341K 0.03% 402
2025
Q1
$2.6K Buy
+725
New +$2.91K ﹤0.01% 1032
2024
Q3
Sell
-162,057
Closed -$199K 1235
2024
Q2
$199K Buy
+162,057
New +$145K 0.02% 476

Other funds holding CLOV

Headlands Technologies's CLOV Position: Q1 2026 in Review

Headlands Technologies increased its Clover Health Investments (CLOV) stake by 31% in Q1 2026, buying an estimated $31.3K and bringing the position to 60,313 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #660.

Headlands Technologies first reported a position in CLOV in Q2 2024 and has held it in 6 quarters since. The position peaked at $292K in Q2 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Headlands Technologies held 60,313 shares of Clover Health Investments worth $106K as of Q1 2026.
  • Headlands Technologies bought 14,434 Clover Health Investments shares in Q1 2026, an estimated $31.3K.
  • Clover Health Investments made up 0.01% of Headlands Technologies's portfolio in Q1 2026, its #660 holding.
  • Headlands Technologies first reported a position in Clover Health Investments in Q2 2024 and has held it in 6 quarters since.
  • Headlands Technologies's Clover Health Investments position peaked at $292K in Q2 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.